Association of rivaroxaban plasma trough concentrations with clinical characteristics and outcomes
Routine monitoring of rivaroxaban plasma concentrations may improve safety in older adults with multiple comorbidities or impaired hepatic, renal, or coagulation functions. Further research is required to establish specific therapeutic thresholds for bleeding and thrombosis.
Authors
- Huizhen Wu (ORCID: https://orcid.org/0000-0001-5858-1969)
- Lanqing Huo (ORCID: https://orcid.org/0000-0002-4578-625X)
- Panpan Jin
- Jing An (ORCID: https://orcid.org/0000-0003-0885-8979)
- Qiaoling Yu
Institutions
- Hebei Medical University (CN)
- Hebei General Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-03-18
- DOI
- https://doi.org/10.3389/fphar.2025.1563745
- Citations
- 2
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.78